Skip to main content
logo
Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
5.23
-0.18 (-3.33%)
Sep 10, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.544.95.174.535.514.47
Revenue Growth
-19.29%-5.22%14.24%-17.77%23.11%443.62%
Gross Profit
-12.05-10.81-20.85-29.24-29.51-15.54
Operating Income
-35.28-31.22-42.44-40.89-36.95-23.82
Net Income
-192.18-173.8-18.92-69.05-36.92-23.16
Earnings Per Share
-5.27-4.80-0.89-1.91-1.08-0.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
23.958.699.2913.5214.8510.29
Total Debt
313.95288.02126.52120.3748.8237.99
Net Cash (Debt)
-290-279.33-117.22-106.85-33.96-27.7
Net Cash Growth
------
Net Cash Per Share
-7.95-7.71-1.98-2.96-0.99-1.15

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.42-25.76-37.55-47.42-32.48-23.58
Capital Expenditures
-0.37-0.54-1.88-8.14-2.21-1.3
Free Cash Flow
-25.79-26.31-39.43-55.57-34.69-24.88
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-217.36%-220.49%----
Operating Margin
-636.55%-636.66%-820.18%-902.85%-670.77%-532.45%
Pretax Margin
-3467.04%-3544.03%-365.60%-1524.51%-670.24%-517.55%
Profit Margin
-3467.04%-3544.03%-365.60%-1524.51%-670.24%-517.55%
FCF Margin
-465.34%-536.40%-762.08%-1226.91%-629.85%-556.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
35.0846.6212.9425.868.1433.18